Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02230410 · ClinicalTrials.gov registry record · NA

Cryo Balloon for Residual Barrett's Esophagus

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
18
Enrollment target

NCT02230410: Completed NA study, sponsored by Mayo Clinic.

NCT02230410 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02230410, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

This study is being done to see if treating residual Barrett's Esophagus after previously having undergone Radiofrequency ablation or Endoscopic Mucosal resection can be eliminated with focal cryotherapy.

Interventions

  • DEVICE CryoBalloon Focal Ablation

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2014-08
Est. Completion 2017-05-26
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT02230410

The ClinicalTrials.gov registry entry for NCT02230410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which CryoBalloon Focal Ablation is the first listed.

NCT02230410 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02230410 about?

NCT02230410 is a clinical study titled "Cryo Balloon for Residual Barrett's Esophagus". This study is being done to see if treating residual Barrett's Esophagus after previously having undergone Radiofrequency ablation or Endoscopic Mucosal resection can be eliminated with focal cryotherapy.

What is the current status of trial NCT02230410?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2014-08. Estimated completion is 2017-05-26.

What interventions are being tested in trial NCT02230410?

The interventions under investigation include: CryoBalloon Focal Ablation (DEVICE).

Who is sponsoring clinical trial NCT02230410?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.